Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.

NCT03330847

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Triple Negative Breast Cancer, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Aurora, Colorado, United States
View all 141 locations
View Trial Details
Active, Not Recruiting

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

NCT02311933

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +9 more
Locations
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 560 locations
View Trial Details
Active, Not Recruiting

A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)

NCT05460273

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +13 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Bengbu, China
View all 21 locations
View Trial Details
Active, Not Recruiting

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

NCT03488693

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Banner-University Medical Center Phoenix Phoenix, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 485 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

NCT02957968

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Virginia Charlottesville, Virginia, United States
  • Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
View Trial Details
Active, Not Recruiting

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

NCT01937117

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details

Related conditions